Imaging findings of right cardiac amyloidosis: impact on prognosis and clinical course.
Amyloidosis
Comorbidity
Echocardiography
Heart disease
Multidisciplinary management
Right heart
TAPSE
Ultrasound
Journal
Journal of ultrasound
ISSN: 1876-7931
Titre abrégé: J Ultrasound
Pays: Italy
ID NLM: 101315005
Informations de publication
Date de publication:
Sep 2023
Sep 2023
Historique:
received:
14
10
2022
accepted:
04
04
2023
medline:
31
8
2023
pubmed:
10
5
2023
entrez:
10
5
2023
Statut:
ppublish
Résumé
Cardiac involvement from amyloidosis is of growing interest in the overall literature. Despite cardiac amyloidosis (CA) has been considered for a long time a rare disease, the diagnostic awareness is increasing mainly thanks to the improvement of diagnostic softwares and of imaging techniques such as cardiac magnetic resonance (CMR). Some authors have observed an increase of prevalence rate of CA; moreover it's often underestimated because clinical manifestations are aspecific. The interstitial infiltration of the left ventricle has been extensively studied, while the involvement of the right ventricle (RV) has been less investigated. Involvement of the RV, even in the absence of pulmonary hypertension or clearly left ventricle infiltration, plays an important role as prognostic factor and is useful to achieve an early diagnosis. Therefore, the use of fast and low-cost diagnostic methods such as ultrasound strain of the right ventricle could be used to recognize cardiac amyloidosis early. Herein the importance of evaluating the right ventricular involvement, which can predict the most severe course of the disease also without overt clinical manifestations. The role of imaging, in particular of echocardiography, CMR, and scintigraphy is here reported.
Identifiants
pubmed: 37162729
doi: 10.1007/s40477-023-00789-1
pii: 10.1007/s40477-023-00789-1
pmc: PMC10171176
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
605-614Informations de copyright
© 2023. Società Italiana di Ultrasonologia in Medicina e Biologia (SIUMB).
Références
Palmiero G, Vetrano E, Rubino M, Monda E, Dongiglio F, Lioncino M, Di Fraia F, Caiazza M, Verrillo F, Capodicasa L, Cerciello G, Manganelli F, Catalano M, D’Arienzo D, De Rimini ML, Ascione R, Golino P, Caso P, Ascione L, Limongelli G (2022) The role of new imaging technologies in the diagnosis of cardiac amyloidosis. Heart Fail Clin 18(1):61–72. https://doi.org/10.1016/j.hfc.2021.07.014 . (Epub 2021 Oct 25, PMID: 34776084)
doi: 10.1016/j.hfc.2021.07.014
pubmed: 34776084
Dorbala S, Ando Y, Bokhari S, Dispenzieri A, Falk RH, Ferrari VA, Fontana M, Gheysens O, Gillmore JD, Glaudemans AWJM, Hanna MA, Hazenberg BPC, Kristen AV, Kwong RY, Maurer MS, Merlini G, Miller EJ, Moon JC, Murthy VL, Quarta CC, Rapezzi C, Ruberg FL, Shah SJ, Slart RHJA, Verberne HJ, Bourque JM (2021) ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: part 1 of 2-evidence base and standardized methods of imaging. Circ Cardiovasc Imaging 14(7):e000029. https://doi.org/10.1161/HCI.0000000000000029 . (Epub 2021 Jul 1, PMID: 34196223)
doi: 10.1161/HCI.0000000000000029
pubmed: 34196223
Bajwa F, O’Connor R, Ananthasubramaniam K (2021) Epidemiology and clinical manifestations of cardiac amyloidosis. Heart Fail Rev. https://doi.org/10.1007/s10741-021-10162-1 . (Epub ahead of print, PMID: 34694575)
doi: 10.1007/s10741-021-10162-1
pubmed: 34694575
Martinez-Naharro A, Hawkins PN, Fontana M (2018) Cardiac amyloidosis. Clin Med (Lond) 18(Suppl 2):s30–s35. https://doi.org/10.7861/clinmedicine.18-2-s30 . (PMID:29700090; PMCID:PMC6334035)
doi: 10.7861/clinmedicine.18-2-s30
pubmed: 29700090
Rubin J, Maurer MS (2020) Cardiac amyloidosis: overlooked, underappreciated, and treatable. Annu Rev Med 27(71):203–219. https://doi.org/10.1146/annurev-med-052918-020140 . (PMID: 31986086)
doi: 10.1146/annurev-med-052918-020140
Wechalekar AD, Gillmore JD, Hawkins PN (2016) Systemic amyloidosis. Lancet 387(10038):2641–2654. https://doi.org/10.1016/S0140-6736(15)01274-X . (Epub 2015 Dec 21, PMID: 26719234, 3)
doi: 10.1016/S0140-6736(15)01274-X
pubmed: 26719234
Gilstrap LG, Dominici F, Wang Y, El-Sady MS, Singh A, Di Carli MF, Falk RH, Dorbala S (2019) Epidemiology of cardiac amyloidosis-associated heart failure hospitalizations among feefor-service medicare beneficiaries in the United States. Circ Heart Fail. 12(6):e005407. https://doi.org/10.1161/CIRCHEARTFAILURE.118.005407 . (Epub 2019 Jun 7, PMID:31170802; PMCID: PMC6557425)
doi: 10.1161/CIRCHEARTFAILURE.118.005407
pubmed: 31170802
pmcid: 6557425
Nitsche C, Scully PR, Patel KP, Kammerlander AA, Koschutnik M, Dona C, Wollenweber T, Ahmed N, Thornton GD, Kelion AD, Sabharwal N, Newton JD, Ozkor M, Kennon S, Mullen M, Lloyd G, Fontana M, Hawkins PN, Pugliese F, Menezes LJ, Moon JC, Mascherbauer J, Treibel TA (2021) Prevalence and outcomes of concomitant aortic stenosis and cardiac amyloidosis. J Am Coll Cardiol. 77(2):128–139. https://doi.org/10.1016/j.jacc.2020.11.006 . (Epub 2020 Nov 9, PMID: 33181246; PMCID: PMC7805267)
doi: 10.1016/j.jacc.2020.11.006
pubmed: 33181246
pmcid: 7805267
Hahn VS, Yanek LR, Vaishnav J, Ying W, Vaidya D, Lee YZJ, Riley SJ, Subramanya V, Brown EE, Hopkins CD, Ononogbu S, Perzel Mandell K, Halushka MK, Steenbergen C Jr, Rosenberg AZ, Tedford RJ, Judge DP, Shah SJ, Russell SD, Kass DA, Sharma K (2020) Endomyocardial biopsy characterization of heart failure with preserved ejection fraction and prevalence of cardiac amyloidosis. JACC Heart Fail. 8(9):712–724. https://doi.org/10.1016/j.jchf.2020.04.007 . (Epub 2020 Jul 8, PMID: 32653448; PMCID: PMC7604801)
doi: 10.1016/j.jchf.2020.04.007
pubmed: 32653448
pmcid: 7604801
Garcia-Pavia P, Rapezzi C, Adler Y, Arad M, Basso C, Brucato A, Burazor I, Caforio ALP, Damy T, Eriksson U, Fontana M, Gillmore JD, Gonzalez-Lopez E, Grogan M, Heymans S, Imazio M, Kindermann I, Kristen AV, Maurer MS, Merlini G, Pantazis A, Pankuweit S, Rigopoulos AG, Linhart A (2021) Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases. Eur Heart J 42(16):1554–1568. https://doi.org/10.1093/eurheartj/ehab072 . (PMID:33825853; PMCID:PMC8060056)
doi: 10.1093/eurheartj/ehab072
pubmed: 33825853
pmcid: 8060056
Writing Committee; Kittleson MM, Ruberg FL, Ambardekar AV, Brannagan TH, Cheng RK, Clarke JO, Dember LM, Frantz JG, Hershberger RE, Maurer MS, Nativi-Nicolau J, Sanchorawala V, Sheikh FH (2023) ACC Expert Consensus Decision Pathway on Comprehensive Multidisciplinary Care for the Patient With Cardiac Amyloidosis: A Report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2023 Mar 21;81(11):1076–1126. https://doi.org/10.1016/j.jacc.2022.11.022
Ternacle J, Krapf L, Mohty D, Magne J, Nguyen A, Galat A, Gallet R, Teiger E, Côté N, Clavel MA, Tournoux F, Pibarot P, Damy T (2019) Aortic stenosis and cardiac amyloidosis: JACC review topic of the week. J Am Coll Cardiol 74(21):2638–2651. https://doi.org/10.1016/j.jacc.2019.09.056 . (PMID: 31753206)
doi: 10.1016/j.jacc.2019.09.056
pubmed: 31753206
Imbriani M, Taino G, Panigazzi M, Capodaglio EM, Oddone E (2019) Active population aging, ICDICF clinical model and occupational and rehabilitation medicine. G Ital Med Lav Ergon 41(2):140–146 (Italian, PMID: 31170344)
pubmed: 31170344
Arvidsson S, Henein MY, Wikström G, Suhr OB, Lindqvist P (2018) Right ventricular involvement in transthyretin amyloidosis. Amyloid 25(3):160–166. https://doi.org/10.1080/13506129.2018.1493989 . (Epub 2018 Sep 7, PMID: 30193533)
doi: 10.1080/13506129.2018.1493989
pubmed: 30193533
Cappelli F, Porciani MC, Bergesio F, Perlini S, Attanà P, Moggi Pignone A, Salinaro F, Musca F, Padeletti L, Perfetto F (2012) Right ventricular function in AL amyloidosis: characteristics and prognostic implication. Eur Heart J Cardiovasc Imaging 13(5):416–422. https://doi.org/10.1093/ejechocard/jer289 . (Epub 2011 Dec 16, PMID: 22180463)
doi: 10.1093/ejechocard/jer289
pubmed: 22180463
Wan K, Lin J, Guo X, Song R, Wang J, Xu Y, Li W, Cheng W, Sun J, Zhang Q, Han Y, Chen Y (2020) Prognostic value of right ventricular dysfunction in patients with AL amyloidosis: comparison of different techniques by cardiac magnetic resonance. J Magn Reson Imaging 52(5):1441–1448. https://doi.org/10.1002/jmri.27200 . (Epub 2020 Jul 20, PMID: 32691470)
doi: 10.1002/jmri.27200
pubmed: 32691470
Ghio S, Perlini S, Palladini G, Marsan NA, Faggiano G, Vezzoli M, Klersy C, Campana C, Merlini G, Tavazzi L (2007) Importance of the echocardiographic evaluation of right ventricular function in patients with AL amyloidosis. Eur J Heart Fail 9(8):808–813. https://doi.org/10.1016/j.ejheart.2007.05.006 . (Epub 2007 Jun 22, PMID: 17586091)
doi: 10.1016/j.ejheart.2007.05.006
pubmed: 17586091
Bodez D, Ternacle J, Guellich A, Galat A, Lim P, Radu C, Guendouz S, Bergoend E, Couetil JP, Hittinger L, Dubois-Randé JL, Plante-Bordeneuve V, Deux JF, Mohty D, Damy T (2016) Prognostic value of right ventricular systolic function in cardiac amyloidosis. Amyloid 23(3):158–167. https://doi.org/10.1080/13506129.2016.1194264 . (Epub 2016 Jun 27, PMID: 27348696)
doi: 10.1080/13506129.2016.1194264
pubmed: 27348696
Mishra T, Pahuja M, Abidov A (2019) Increasingly Recognized Role of Right Ventricle Assessment in Cardiac Amyloidosis. JACC Heart Fail 7(3):277–278. https://doi.org/10.1016/j.jchf.2018.11.014 . (PMID: 30819388)
doi: 10.1016/j.jchf.2018.11.014
pubmed: 30819388
Uzan C, Lairez O, Raud-Raynier P, Garcia R, Degand B, Christiaens LP, Rehman MB (2018) Right ventricular longitudinal strain: a tool for diagnosis and prognosis in light-chain amyloidosis. Amyloid 25(1):18–25. https://doi.org/10.1080/13506129.2017.1417121 . (Epub 2017 Dec 20, PMID: 29260587)
doi: 10.1080/13506129.2017.1417121
pubmed: 29260587
Merlini G, Bellotti V (2003) Molecular mechanisms of amyloidosis. N Engl J Med 349(6):583–596. https://doi.org/10.1056/NEJMra023144 . (PMID: 12904524)
doi: 10.1056/NEJMra023144
pubmed: 12904524
Phelan D, Collier P, Thavendiranathan P, Popović ZB, Hanna M, Plana JC, Marwick TH, Thomas JD (2012) Relative apical sparing of longitudinal strain using two-dimensional speckle tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis. Heart 98(19):1442–1448. https://doi.org/10.1136/heartjnl-2012-302353 . (Epub 2012 Aug 3, PMID: 22865865)
doi: 10.1136/heartjnl-2012-302353
pubmed: 22865865
Hashimoto H, Kurata A, Mizuno H, Nashiro T, Hangaishi A, Kuroda M, Usuki K, Horiuchi H (2015) Pulmonary arterial hypertension due to pulmonary vascular amyloid deposition in a patient with multiple myeloma. Int J Clin Exp Pathol. 8(11):15391–15395 (PMID: 26823900; PMCID: PMC4713686)
pubmed: 26823900
pmcid: 4713686
Luz AE, Schneider U, Ehlerding G, Frenzel H, Koch KM, Kühn K (1995) Right ventricular cardiac failure and pulmonary hypertension in a long-term dialysis patient–unusual presentation of visceral beta 2-microglobulin amyloidosis. Nephrol Dial Transplant 10(4):555–558. https://doi.org/10.1093/ndt/10.4.555 . (PMID: 7624004)
doi: 10.1093/ndt/10.4.555
Giancaterino S, Urey MA, Darden D, Hsu JC (2020) Management of arrhythmias in cardiac amyloidosis. JACC Clin Electrophysiol 6(4):351–361. https://doi.org/10.1016/j.jacep.2020.01.004 . (PMID: 32327068)
doi: 10.1016/j.jacep.2020.01.004
pubmed: 32327068
Ballantyne B, Manian U, Sheyin O, Davey R, De S (2020) Stroke risk and atrial mechanical dysfunction in cardiac amyloidosis. ESC Heart Fail. 7(2):705–707. https://doi.org/10.1002/ehf2.12602 . (Epub 2020 Jan 21, PMID: 31965737; PMCID: PMC7160485)
doi: 10.1002/ehf2.12602
pubmed: 31965737
pmcid: 7160485
Hiroshima Y, Sugaya A, Aizawa K, Kawahito K (2019) Right atrium thrombus due to cardiac amyloidosis; Report of a case. Kyobu Geka 72(11):931–934 (Japanese, PMID: 31588112)
pubmed: 31588112
Vergaro G, Aimo A, Rapezzi C, Castiglione V, Fabiani I, Pucci A, Buda G, Passino C, Lupón J, Bayes-Genis A, Emdin M, Braunwald E (2022) Atrial amyloidosis: mechanisms and clinical manifestations. Eur J Heart Fail 24(11):2019–2028. https://doi.org/10.1002/ejhf.2650 . (Epub 2022 Aug 21, PMID: 35920110)
doi: 10.1002/ejhf.2650
pubmed: 35920110
Sukhacheva TV, Eremeeva MV, Ibragimova AG, Vaskovskii VA, Serov RA, Revishvili ASh (2016) Isolated atrial amyloidosis in patients with various types of atrial fibrillation. Bull Exp Biol Med 160(6):844–849. https://doi.org/10.1007/s10517-016-3324-3 . (Epub 2016 May 10, PMID: 27160887)
doi: 10.1007/s10517-016-3324-3
pubmed: 27160887
Di Bella G, Cappelli F, Licordari R, Piaggi P, Campisi M, Bellavia D, Minutoli F, Gentile L, Russo M, de Gregorio C, Perfetto F, Mazzeo A, Falletta C, Clemenza F, Vita G, Carerj S, Aquaro GD (2022) Prevalence and diagnostic value of extra-left ventricle echocardiographic findings in transthyretin-related cardiac amyloidosis. Amyloid 29(3):197–204. https://doi.org/10.1080/13506129.2022.2064739 . (Epub 2022 Apr 23, PMID: 35465808)
doi: 10.1080/13506129.2022.2064739
pubmed: 35465808
Jurcuţ R, Onciul S, Adam R, Stan C, Coriu D, Rapezzi C, Popescu BA (2020) Multimodality imaging in cardiac amyloidosis: a primer for cardiologists. Eur Heart J Cardiovasc Imaging 21(8):833–844. https://doi.org/10.1093/ehjci/jeaa063 . (PMID: 32393965)
doi: 10.1093/ehjci/jeaa063
pubmed: 32393965
Klein AL, Tajik AJ (1991) Doppler assessment of diastolic function in cardiac amyloidosis. Echocardiography 8(2):233–251. https://doi.org/10.1111/j.1540-8175.1991.tb01394.x . (PMID: 10149254)
doi: 10.1111/j.1540-8175.1991.tb01394.x
pubmed: 10149254
Fontana M, Ćorović A, Scully P, Moon JC (2019) Myocardial amyloidosis: the exemplar interstitial disease. JACC Cardiovasc Imaging 12(11 Pt 2):2345–2356. https://doi.org/10.1016/j.jcmg.2019.06.023 . (Epub 2019 Aug 14, PMID: 31422120)
doi: 10.1016/j.jcmg.2019.06.023
pubmed: 31422120
Bellavia D, Pellikka PA, Dispenzieri A et al (2012) Comparison of right ventricular longitudinal strain imaging, tricuspid annular plane systolic excursion, and cardiac biomarkers for early diagnosis of cardiac involvement and risk stratification in primary systematic (AL) amyloidosis: a 5-year cohort study. Eur Heart J Cardiovasc Imaging 13(8):680–689
doi: 10.1093/ehjci/jes009
pubmed: 22307866
Licordari R, Minutoli F, Recupero A, Campisi M, Donato R, Mazzeo A, Dattilo G, Baldari S, Vita G, Zito C, Di Bella G (2021) Early impairment of right ventricular morphology and function in transthyretin-related cardiac amyloidosis. J Cardiovasc Echogr. 31(1):17–22. https://doi.org/10.4103/jcecho.jcecho_112_20 . (Epub 2021 May 21, PMID: 34221881; PMCID:PMC8230159)
doi: 10.4103/jcecho.jcecho_112_20
pubmed: 34221881
pmcid: 8230159
Rapezzi C, Merlini G, Quarta CC et al (2009) Systemic cardiac amyloidosis: disease profiles and clinical courses of the 3 main types. Circulation 120(13):1203–1212
doi: 10.1161/CIRCULATIONAHA.108.843334
pubmed: 19752327
Falk RH, Alexander KM, Liao R et al (2016) AL (light-chain) cardiac amyloidosis: a review of diagnosis and therapy. J Am Coll Cardiol 68(12):1323–1341
doi: 10.1016/j.jacc.2016.06.053
pubmed: 27634125
Urbano-Moral JA, Gangadharamurthy D, Comenzo RL, Pandian NG, Patel AR (2015) Threedimensional speckle tracking echocardiography in light chain cardiac amyloidosis: examination of left and right ventricular myocardial mechanics parameters. Rev Esp Cardiol (Engl Ed). 68(8):657–664. https://doi.org/10.1016/j.rec.2015.01.009 . (Epub 2015 Jun 17, PMID: 26092748)
doi: 10.1016/j.rec.2015.01.009
pubmed: 26092748
Moñivas Palomero V, Durante-Lopez A, Sanabria MT, Cubero JS, González-Mirelis J, Lopez- Ibor JV, Navarro Rico SM, Krsnik I, Dominguez F, Mingo AM, Hernandez-Perez FJ, Cavero G, Santos SM (2019) Role of right ventricular strain measured by two-dimensional echocardiography in the diagnosis of cardiac amyloidosis. J Am Soc Echocardiogr 32(7):845-853.e1. https://doi.org/10.1016/j.echo.2019.03.005 . (Epub 2019 May 8, PMID: 31078369)
doi: 10.1016/j.echo.2019.03.005
pubmed: 31078369
Nemes A, Földeák D, Domsik P, Kalapos A, Kormányos Á, Borbényi Z, Forster T (2018) Right atrial deformation analysis in cardiac amyloidosis—results from the three-dimensional speckle-tracking echocardiographic MAGYAR-path study. Arq Bras Cardiol. 111(3):384–391. https://doi.org/10.5935/abc.20180150 . (Epub 2018 Aug 20, PMID: 30133551; PMCID: PMC6173351)
doi: 10.5935/abc.20180150
pubmed: 30133551
pmcid: 6173351
Singulane CC, Slivnick JA, Addetia K, Asch FM, Sarswat N, Soulat-Dufour L, Mor-Avi V, Lang RM (2022) Prevalence of right atrial impairment and association with outcomes in cardiac amyloidosis. J Am Soc Echocardiogr 35(8):829-835.e1. https://doi.org/10.1016/j.echo.2022.03.022 . (Epub 2022 Apr 7, PMID: 35398489)
doi: 10.1016/j.echo.2022.03.022
pubmed: 35398489
Miller F Jr, Bellavia D (2013) Comparison of right ventricular longitudinal strain imaging, tricuspidannular plane systolic excursion, and cardiac biomarkers for early diagnosis of cardiac involvement and risk stratification in primary systematic (AL) amyloidosis: a 5-year cohort study: reply. Eur Heart J Cardiovasc Imaging 14(1):91–92. https://doi.org/10.1093/ehjci/jes227 . (PMID: 23362526)
doi: 10.1093/ehjci/jes227
pubmed: 23362526
Granstam SO, Rosengren S, Vedin O, Kero T, Sörensen J, Carlson K, Flachskampf FA, Wikström G (2013) Evaluation of patients with cardiac amyloidosis using echocardiography, ECG and right heart catheterization. Amyloid 20(1):27–33. https://doi.org/10.3109/13506129.2012.761967 . (Epub 2013 Jan 22 PMID: 23339421)
doi: 10.3109/13506129.2012.761967
pubmed: 23339421
Ahmad MM, Basraon J, Razzaque I, Port SC, Ammar KA (2018) The complementary nature of tissue Doppler to 99mTc-PYP imaging in diagnosis of right ventricular cardiac amyloidosis. J Nucl Cardiol 25(4):1412–1414. https://doi.org/10.1007/s12350-017-0882-3 . (Epub 2017 Apr 21, PMID: 28432670)
doi: 10.1007/s12350-017-0882-3
pubmed: 28432670
Lindqvist P, Olofsson BO, Backman C, Suhr O, Waldenström A (2006) Pulsed tissue Doppler and strain imaging discloses early signs of infiltrative cardiac disease: a study on patients with familial amyloidotic polyneuropathy. Eur J Echocardiogr 7(1):22–30. https://doi.org/10.1016/j.euje.2005.03.004 . (PMID: 15869906)
doi: 10.1016/j.euje.2005.03.004
pubmed: 15869906
Tadic M, Kersten J, Nita N, Schneider L, Buckert D, Gonska B, Scharnbeck D, Dahme T, Imhof A, Belyavskiy E, Cuspidi C, Rottbauer W (2021) The prognostic importance of right ventricular longitudinal strain in patients with cardiomyopathies, connective tissue diseases, coronary artery disease, and congenital heart diseases. Diagnostics (Basel) 11(6):954. https://doi.org/10.3390/diagnostics11060954 . (PMID:34073460; PMCID:PMC8228710)
doi: 10.3390/diagnostics11060954
pubmed: 34073460
Tjahjadi C, Fortuni F, Stassen J, Debonnaire P, Lustosa RP, Marsan NA, Delgado V, Bax JJ (2022) Prognostic implications of right ventricular systolic dysfunction in cardiac amyloidosis. Am J Cardiol 15(173):120–127. https://doi.org/10.1016/j.amjcard.2022.02.048 . (Epub 2022 Apr 1, PMID: 35369931)
doi: 10.1016/j.amjcard.2022.02.048
Bartolini S, Baldasseroni S, Fattirolli F, Silverii MV, Piccioli L, Perfetto F, Marchionni N, Di Mario C, Martone R, Taborchi G, Morini S, Vignini E, Cappelli F (2021) Poor right ventricular function is associated with impaired exercise capacity and ventilatory efficiency in transthyretin cardiac amyloid patients. Intern Emerg Med 16(3):653–660. https://doi.org/10.1007/s11739-020-02474-1 . (Epub 2020 Sep 12, PMID: 32918156)
doi: 10.1007/s11739-020-02474-1
pubmed: 32918156
Francone M, Aquaro GD, Barison A, Castelletti S, de Cobelli F, de Lazzari M, Esposito A, Focardi M, di Renzi P, Indolfi C, Lanzillo C, Lovato L, Maestrini V, Mercuro G, Natale L, Mantini C, Polizzi G, Rabbat M, Secchi F, di Cesare E, Pontone G (2021) Appropriate use criteria for cardiovascular MRI: SIC— SIRM position paper part 2 (myocarditis, pericardial disease, cardiomyopathies and valvular heart disease). J Cardiovasc Med (Hagerstown) 22(7):515–529. https://doi.org/10.2459/JCM.0000000000001170 . (PMID: 34076599)
doi: 10.2459/JCM.0000000000001170
pubmed: 34076599
White SK et al (2013) T1 mapping for myocardial extracellular volume measurement by CMR bolus only versus primed infusion technique. JACC Cardiovasc Imaging 6:955–962
doi: 10.1016/j.jcmg.2013.01.011
pubmed: 23582361
Mavrogeni SI, Vartela V, Ntalianis A, Vretou R, Ikonomidis I, Tselegkidou M, Paraskevaidis I, Markousis-Mavrogenis G, Noutsias M, Rigopoulos A, Kolovou G, Kastritis E (2021) Cardiac amyloidosis: in search of the ideal diagnostic tool. Herz 46(Suppl 1):9–14. https://doi.org/10.1007/s00059-019-04871-5 . (English, Epub 2019 Dec 3, PMID: 31796976)
doi: 10.1007/s00059-019-04871-5
pubmed: 31796976
Syed IS, Glockner JF, Feng D, Araoz PA, Martinez MW, Edwards WD, Gertz MA, Dispenzieri A, Oh JK, Bellavia D, Tajik AJ, Grogan M (2010) Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis. JACC Cardiovasc Imaging 3(2):155–164. https://doi.org/10.1016/j.jcmg.2009.09.023 . (PMID: 20159642)
doi: 10.1016/j.jcmg.2009.09.023
pubmed: 20159642
Rehwald WG, Fieno DS, Chen EL, Kim RJ, Judd RM (2002) Myocardial magnetic resonance imaging contrast agent concentrations after reversible and irreversible ischemic injury. Circulation 105:224–229
doi: 10.1161/hc0202.102016
pubmed: 11790705
Fontana M et al (2014) Native T1 mapping in transthyretin amyloidosis. JACC Cardiovasc Imaging 7:157–165
doi: 10.1016/j.jcmg.2013.10.008
pubmed: 24412190
Eckstein J, Körperich H, Weise Valdés E, Sciacca V, Paluszkiewicz L, Burchert W, Farr M, Sommer P, Sohns C, Piran M (2022) CMR-based right ventricular strain analysis in cardiac amyloidosis and its potential as a supportive diagnostic feature. Int J Cardiol Heart Vasc. 44:101167. https://doi.org/10.1016/j.ijcha.2022.101167 . (PMID: 36632287; PMCID: PMC9827025)
doi: 10.1016/j.ijcha.2022.101167
pubmed: 36632287
pmcid: 9827025
Steen H, Giusca S, Montenbruck M, Patel AR, Pieske B, Florian A, Erley J, Kelle S, Korosoglou G (2021) Left and right ventricular strain using fast strain-encoded cardiovascular magnetic resonance for the diagnostic classification of patients with chronic non-ischemic heart failure due to dilated, hypertrophic cardiomyopathy or cardiac amyloidosis. J Cardiovasc Magn Reson 23(1):45. https://doi.org/10.1186/s12968-021-00711-w.PMID:33823860;PMCID:PMC8025329
doi: 10.1186/s12968-021-00711-w.PMID:33823860;PMCID:PMC8025329
pubmed: 33823860
pmcid: 8025329
Eckstein J, Sciacca V, Körperich H, Paluszkiewicz L, Valdés EW, Burchert W, Gerçek M, Farr M, Sommer P, Sohns C, Piran M (2022) Cardiovascular magnetic resonance imaging-based right atrial strain analysis of cardiac amyloidosis. Biomedicines 10(12):3004. https://doi.org/10.3390/biomedicines10123004 . (PMID:36551760; PMCID:PMC9775378)
doi: 10.3390/biomedicines10123004
pubmed: 36551760
pmcid: 9775378
Eckstein J, Moghadasi N, Körperich H, Weise Valdés E, Sciacca V, Paluszkiewicz L, Burchert W, Piran M (2022) A machine learning challenge: detection of cardiac amyloidosis based on bi-atrial and right ventricular strain and cardiac function. Diagnostics (Basel) 12(11):2693. https://doi.org/10.3390/diagnostics12112693 . (PMID:36359536; PMCID:PMC9689404)
doi: 10.3390/diagnostics12112693
pubmed: 36359536
Mattana F, Muraglia L, Girardi F, Cerio I, Porcari A, Dore F, Bonfiglioli R, Fanti S (2022) Clinical application of cardiac scintigraphy with bone tracers: controversies and pitfalls in cardiac amyloidosis. Vessel Plus 6:13. https://doi.org/10.20517/2574-1209.2021.87
doi: 10.20517/2574-1209.2021.87
Bokhari S et al (2013) (99m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses. Circ Cardiovasc Imaging 6:195–201
doi: 10.1161/CIRCIMAGING.112.000132
pubmed: 23400849
pmcid: 3727049
Castano A et al (2016) Multicenter study of planar technetium 99m pyrophosphate cardiac imaging: predicting survival for patients with ATTR cardiac amyloidosis. JAMA Cardiol 1:880–889
doi: 10.1001/jamacardio.2016.2839
pubmed: 27557400
Perugini E et al (2005) Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3- diphosphono- 1,2-propanodicarboxylic acid scintigraphy. J Am Coll Cardiol 46:1076–1084
doi: 10.1016/j.jacc.2005.05.073
pubmed: 16168294
Rapezzi C et al (2011) Role of (99m)Tc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretinrelatedg cardiac amyloidosis. JACC Cardiovasc Imaging 4:659–670
doi: 10.1016/j.jcmg.2011.03.016
pubmed: 21679902
Falk RH, Lee VW, Rubinow A, Hood WB Jr, Cohen AS (1983) Sensitivity of technetium-99m-pyrophosphate scintigraphy in diagnosing cardiac amyloidosis. Am J Cardiol 51:826–830
doi: 10.1016/S0002-9149(83)80140-4
pubmed: 6299087
Raina S, Lensing SY, Nairooz RS, Pothineni NV, Hakeem A, Bhatti S, Pandey T (2016) Prognostic value of late gadolinium enhancement CMR in systemic amyloidosis. JACC Cardiovasc Imaging 9(11):1267–1277. https://doi.org/10.1016/j.jcmg.2016.01.036 . (Epub 2016 Aug 24, PMID: 27568115)
doi: 10.1016/j.jcmg.2016.01.036
pubmed: 27568115
Wan K, Sun J, Han Y, Luo Y, Liu H, Yang D, Cheng W, Zhang Q, Zeng Z, Chen Y (2018) Right ventricular involvement evaluated by cardiac magnetic resonance imaging predicts mortality in patients with light chain amyloidosis. Heart Vessels 33(2):170–179. https://doi.org/10.1007/s00380-017-1043-y3 . (Epub 2017 Aug 24; PMID: 28840397; PMCID: PMC5766713)
doi: 10.1007/s00380-017-1043-y3
pubmed: 28840397
Li X, Li J, Lin L, Shen K, Tian Z, Sun J, Zhang C, An J, Jin Z, Vliegenthart R, Selvanayagam JB, Wang Y (2020) Left and right ventricular myocardial deformation and late gadolinium enhancement: incremental prognostic value in amyloid light-chain amyloidosis. Cardiovasc Diagn Ther 10(3):470–480. https://doi.org/10.21037/cdt-20-181 . (PMID:32695626; PMCID:PMC7369280)
doi: 10.21037/cdt-20-181
pubmed: 32695626
pmcid: 7369280
Gertz MA, Li CY, Shirahama T, Kyle RA (1988) Utility of subcutaneous fat aspiration for the diagnosis of systemic amyloidosis (immunoglobulin light chain). Arch Intern Med 148(4):929–933 (PMID: 2451487)
doi: 10.1001/archinte.1988.00380040169024
pubmed: 2451487
Siddiqi OK, Ruberg FL (2017) Challenging the myths of cardiac amyloidosis. Eur Heart J 38(24):1909–1912. https://doi.org/10.1093/eurheartj/ehx210 . (PMID: 28444296)
doi: 10.1093/eurheartj/ehx210
pubmed: 28444296
Shah Z, Rali A, Gupta K (2019) National trends and procedural complications from endomyocardial biopsy: results from the national inpatient sample, 2007–2014. Cardiology 142(4):223. https://doi.org/10.1159/000500113 . (Epub 2019 Jun 18, PMID: 31212282)
doi: 10.1159/000500113
pubmed: 31212282